Nodular Sclerosis Classic Hodgkin Lymphoma

Nodular Sclerosis Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02168140	CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma	completed	Phase 1	16	Wake Forest University Health SciencesOTHER	1	Feb 13, 2024	clinicaltrials
NCT01535924	Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma	completed	Phase 1 / Phase 2	26	Beth ChristianOTHER	1	Nov 19, 2021	clinicaltrials